Purpose
Drug of Abuse Monitoring
Method(s)
Gas Chromatography (GC)
Suggested CPT Code(s)
80323
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 Mescaline 3,4,5-Trimethoxyphenethylamine; Peyote Gas Chromatography (GC) mcg/mL 0.02 Hallucinogen

Specimen Type
Serum or Plasma
Requested Volume
3 mL
Minimum Volume
1.2 mL
Special Handling
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Polymer gel separation tube (SST or PST).

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 30 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): 30 day(s)
1 Mescaline 3,4,5-Trimethoxyphenethylamine; Peyote Gas Chromatography (GC) mcg/mL 0.02 Hallucinogen

Interface Map

LOINC® Information